Albireo Pharma (ALBO) 10-Q2020 Q1 Quarterly report

Filed: 7 May 20, 8:06am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: abatement, added, adult, afflicted, alteration, avoid, BOLD, building, chain, China, cleared, Cloud, collected, collectively, confidence, construction, contact, daily, delivery, desire, distancing, evolve, Expansion, federal, feet, forced, geographic, Goodwill, home, hospital, hosting, insurance, integrity, interruption, job, launch, LLC, located, lost, native, NS, outbreak, Owner, pandemic, permitted, pertaining, placebo, PO, POSIG, Post, quarantine, randomized, recommended, rentable, return, Rule, sBA, secondary, sequestrant, serum, serving, SHIGO, site, social, software, spread, strain, Subtopic, successor, surfaced, topline, travel, unfavorable, volatile, withdrawing, worsen, Wuhan

Removed: accounted, allocation, amortization, applied, assessed, assessing, automatically, breached, capitalization, Center, citing, classification, committed, committee, comparative, compensatory, complaint, compliant, consecutive, consideration, Consumer, contingency, contingent, COSO, counsel, County, Court, covenant, dealing, decided, deduction, deficiency, detected, determined, dilutive, discussed, distribution, District, earned, Echo, efficacy, ending, enhanced, entitled, equipment, escalating, Euro, expiration, expired, faith, fee, Ferring, foot, framework, fully, good, hindsight, idiopathic, impairment, improve, Index, ingredient, instance, insufficient, International, issue, Labour, leased, leasing, legacy, lessee, likelihood, litigate, litigating, litigation, longer, maintaining, matter, Ministry, misstatement, model, nature, netted, November, offered, opening, operation, package, Parent, perform, practical, prevented, procedural, procurement, protracted, qualify, qualifying, real, reassessed, recognize, recovery, refile, reliable, Relief, remediate, remediated, remediation, renewal, rental, replace, Respondent, retained, revision, ROU, safety, seeking, selling, Southern, Sponsoring, stopped, Supreme, Sweden, Swedish, Topic, transition, Treadway, ultimately, unrelated, variable, violated, Welfare, York

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated ALBO transcripts

ALBO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATIONS UNDER SECTION 906

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Albireo Pharma, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report for the quarter ended March 31, 2020 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated: May 7, 2020		/s/ Ronald H.W. Cooper
		Ronald H.W. Cooper
		President and Chief Executive Officer
		(principal executive officer)


Dated: May 7, 2020		/s/ Simon Harford
		Simon N.R. Harford
		Chief Financial Officer and Treasurer
		(principal financial officer and principal accounting officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.